Russian consensus on prevention, diagnosis and treatment of gastric cancer. Questions of instrumental diagnostics
I. D. Amelina,
Z. V. Galkova,
B. I. Dolgushin,
R. E. Izrailov,
G. G. Karmazanovskii,
S. V. Kashin,
V. A. Kim,
Yu. V. Kulezneva,
O. A. Malikhova,
B. M. Medvedeva,
I. Yu. Nedoluzhko,
E. V. Parfenchikova,
S. S. Pirogov,
N. E. Semenov,
E. N. Solodinina,
Yu. G. Starkov,
O. B. Tkachenko,
L. N. Shevkunov,
K. V. Shishin,
V. V. Shchadrova https://doi.org/10.18027/2224-5057-2024-047
Abstract
The Russian consensus on prevention, diagnostic and treatment of gastric cancer was prepared on the initiative of the Moscow clinical scientific center named after A. S. Loginov on the Delphi method.
Its aim was to clarify and consolidate the opinions of specialists on the most relevant issues of prevention, diagnosis and treatment of gastric cancer.
An interdisciplinary approach was provided by the participation of leading gastroenterologists, oncologists and surgeons.
Supporting agencies: The article was prepared without sponsorship
About the Authors
I. D. Amelina
N. N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Inna Dmitrievna Amelina
197758; 68 Leningradskaya St.; Saint Petersburg; Pesochnyy
Competing Interests:
The authors declare that there are no possible conflicts of interest
Z. V. Galkova
N. I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Zalina Viktorovna Galkova
117997; 1 Ostrovityanova St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
B. I. Dolgushin
A. I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Boris Ivanovich Dolgushin
127473; Build. 1, 20 Delegatskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
R. E. Izrailov
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Roman Evgenevich Izrailov
111123; Build. 1, 1 Novogireevskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
G. G. Karmazanovskii
A. V. Vishnevsky National Medical Research Center of Surgery
Russian Federation
Competing Interests:
Russian Federation
Grigorii Grigorevich Karmazanovskii
117997; 27 Bolshaya Serpukhovskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
S. V. Kashin
Yaroslavl State Medical University
Russian Federation
Competing Interests:
Russian Federation
150000; 5 Revolyutsionnaya St.; Yaroslavl
Competing Interests:
The authors declare that there are no possible conflicts of interest
V. A. Kim
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Viktoriya Anatolevna Kim
111123; Build. 1, 1 Novogireevskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
Yu. V. Kulezneva
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Yuliya Valerevna Kulezneva
111123; Build. 1, 1 Novogireevskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
O. A. Malikhova
N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Olga Aleksandrovna Malikhova
115478; 23 Kashirskoe Shosse; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
B. M. Medvedeva
N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Bela Mikhailovna Medvedeva
115478; 23 Kashirskoe Shosse; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
I. Yu. Nedoluzhko
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Ivan Yurevich Nedoluzhko
111123; Build. 1, 1 Novogireevskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
E. V. Parfenchikova
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Elena Vladimirovna Parfenchikova
111123; Build. 1, 1 Novogireevskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
S. S. Pirogov
P. A. Hertsen Moscow Oncology Research Institute — branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Sergei Sergeevich Pirogov
125284; 3 2nd Botkinskiy proezd; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
N. E. Semenov
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Nikolai Evgenevich Semenov
111123; Build. 1, 1 Novogireevskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
E. N. Solodinina
Ilyinskaya hospital
Russian Federation
Competing Interests:
Russian Federation
Elena Nikolaevna Solodinina
143421; Build 2, 2 Gluhovo, Rublevskoe predmeste St.; Moscow Region
Competing Interests:
The authors declare that there are no possible conflicts of interest
Yu. G. Starkov
A. V. Vishnevsky National Medical Research Center of Surgery
Russian Federation
Competing Interests:
Russian Federation
117997; 27 Bolshaya Serpukhovskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
O. B. Tkachenko
N. N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Oleg Borisovich Tkachenko
197758; 68 Leningradskaya St.; Pesochnyy; Saint Petersburg
Competing Interests:
The authors declare that there are no possible conflicts of interest
L. N. Shevkunov
N. I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation
Competing Interests:
Russian Federation
Lev Nikolaevich Shevkunov
117997; 1 Ostrovityanova St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
K. V. Shishin
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Kirill Vyacheslavovich Shishin
111123; Build. 1, 1 Novogireevskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
V. V. Shchadrova
A. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Viktoriya Vasilevna Shchadrova
111123; Build. 1, 1 Novogireevskaya St.; Moscow
Competing Interests:
The authors declare that there are no possible conflicts of interest
References
1. Smyth E.C., Verheij M., Allum W., et al. ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27(suppl 5):v38-v49. doi: 10.1093/annonc/mdw350
2. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5<sup>th</sup> edition). Gastric Cancer 2021;24(1):1–21. doi: 10.1007/s10120-020-01041-y
3. NCCN Clinical Practice Guideline in. Gastric Cancer version 3.2020. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf
4. Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multidisciplinary Approach. J Gastric Cancer. 2019 Mar;19(1):1–48. doi: 10.5230/jgc.2019.19.e8. Epub 2019 Mar 19. Erratum in: J Gastric Cancer. 2019 Sep;19(3):372–373
5. Matsumura S., Dohi O., Yamada N, et al. Improved visibility of early gastric cancer after successful Helicobacter pylori eradication with image-enhanced endoscopy: A multi-institutional study using video clips. J Clin Med 2021;10(16):3649. doi: 10.3390/jcm10163649
6. Kawahara Y., Takenaka R., Okada H., et al. Novel chromoendoscopic method using an acetic acid-indigocarmine mixture for diagnostic accuracy in delineating the margin of early gastric cancers. Dig Endosc 2009;21(1):14–9. doi: 10.1111/j.1443-1661.2008.00824.x
7. Matsumoto Y., Yanai H., Tokiyama H., et al. Endoscopic ultrasonography for diagnosis of submucosal invasion in early gastric cancer. J Gastroenterol 2000;35(5):326–31. doi: 10.1007/s005350050356
8. Puli S.R., Batapati Krishna Reddy J., Bechtold M.L., et al. How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review. World J Gastroenterol 2008;14(25):4011–9. doi: 10.3748/wjg.14.4011
9. Bergman J.J., Fockens P. Endoscopic ultrasonography in patients with gastro-esophageal cancer. Eur J Ultrasound 1999;10(2–3):127–38. doi: 10.1016/s0929-8266(99)00055-5
10. Lee K.G., Shin C.I., Kim S.G., et al. Can endoscopic ultrasonography (EUS) improve the accuracy of clinical T staging by computed tomography (CT) for gastric cancer? Eur J Surg Oncol 2021;47(8):1969–1975. doi: 10.1016/j.ejso.2021.02.031
11. Kaurah P., Huntsman D.G. Hereditary Diffuse Gastric Cancer. 2002 Nov 4 [updated 2018 Mar 22. In: Adam M.P., Ardinger H.H., Pagon R.A., et al. editors. GeneReviews® Internet. Seattle (WA): University of Washington, Seattle; 1993–2022
12. Cha R.R., Cho J.K., Kim W.S., et al. Primary gastric small cell carcinoma (presenting as linitis plastica) diagnosed using endoscopic ultrasound-guided biopsy: a case report. Clin Endosc 2019;52(3):278–282. doi: 10.5946/ce.2018.114
13. Jung K., Park M.I., Kim S.E., Park S.J. Borrmann type 4 advanced gastric cancer: focus on the development of scirrhous gastric cancer. Clin Endosc 2016;49(4):336–45. doi: 10.5946/ce.2016.057
14. Morgant S., Artru P., Oudjit A., et al. Endoscopic ultrasound efficacy in staging gastric linitis plastica lesion: a retrospective multicentric French study. Ann Transl Med 2021;9(1):50. doi: 10.21037/atm-20-3474
15. Qiu H., Zhou Z. Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5. Zhonghua Wei Chang Wai Ke Za Zhi 2018;21(2):160–164
16. Cardoso R., Coburn N., Seevaratnam R., et al. A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer. Gastric Cancer 2012;15 Suppl 1:S19–26. doi: 10.1007/s10120-011-0115-4
17. Smyth E.C., Verheij M., Allum W., et al. ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27(suppl 5):v38-v49. doi: 10.1093/annonc/mdw350
18. Bentrem D., Gerdes H, Tang L, Brennan M, Coit D. Clinical correlation of endoscopic ultrasonography with pathologic stage and outcome in patients undergoing curative resection for gastric cancer. Ann Surg Oncol 2007;14(6):1853–9. doi: 10.1245/s10434-006-9037-5
19. Lee M.H., Choi D., Park M.J., Lee M.W. Gastric cancer: imaging and staging with MDCT based on the 7<sup>th</sup> AJCC guidelines. Abdom Imaging 2012;37(4):531–40. doi: 10.1007/s00261-011-9780-3
20. Guniganti P., Bradenham C.H., Raptis C., et al. CT of Gastric Emergencies. Radiographics. 2015;35(7):1909–21. doi: 10.1148/rg.2015150062
21. Agababyan T.A. Diagnosis of Extraorgan Spread of Gastric Cancer (T Category) by Multislice Computed Tomography: Error Analysis. Medical Imaging. 2012;3:33–40 (In Russ.).
22. Shimizu K., Ito K., Matsunaga N., et al. Diagnosis of gastric cancer with MDCT using the water-filling method and multiplanar reconstruction: CT-histologic correlation. AJR Am J Roentgenol 2005;185(5):1152–8. doi: 10.2214/AJR.04.0651
23. Park H.S., Kim Y.J., Ko S.Y., et al. Benign regional lymph nodes in gastric cancer on multidetector row CT. Acta Radiol 2012;53(5):501–7. doi: 10.1258/ar.2012.120054
24. Wei W.Z., Yu J.P., Li J., et al. Evaluation of contrast-enhanced helical hydro-CT in staging gastric cancer. World J Gastroenterol 2005;11(29):4592–5. doi: 10.3748/wjg.v11.i29.4592
25. Seevaratnam R., Cardoso R., McGregor C., et al. How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer 2012;15 Suppl 1:S3–18. doi: 10.1007/s10120-011-0069-6
26. Hu Y.F., Deng Z.W., Liu H., et al. Staging laparoscopy improves treatment decision-making for advanced gastric cancer. World J Gastroenterol. 2016;22(5):1859–68. doi: 10.3748/wjg.v22.i5.1859
27. Jang G.S., Kim M.J., Ha H.I., et al. Comparison of RECIST version 1.0 and 1.1 in assessment of tumor response by computed tomography in advanced gastric cancer. Chin J Cancer Res 2013;25(6):689–94. doi: 10.3978/j.issn.1000-9604.2013.11.09
28. Xu X., Zheng G., Zhang T., et al. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response. Cancer Chemother Pharmacol 2019;84(3):635–646. doi: 10.1007/s00280-019-03893-4
29. Kim J.H., Heo S.H., Kim J.W., et al. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography. World J Gastroenterol 2017;23(35):6448–6456. doi: 10.3748/wjg.v23.i35.6448
30. Kim D.W., Park S.A., Kim C.G. Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT. J Korean Med Sci 2011;26(7):875–80. doi: 10.3346/jkms.2011.26.7.875
31. Kim S.K., Kang K.W., Lee J.S., et al. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006;33(2):148–55. doi: 10.1007/s00259-005-1887-8
32. Wu C.X., Zhu Z.H. Diagnosis and evaluation of gastric cancer by positron emission tomography. World J Gastroenterol 2014;20(16):4574–85. doi: 10.3748/wjg.v20.i16.4574
33. Yun M. Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT. J Gastric Cancer 2014;14(1):1–6. doi: 10.5230/jgc.2014.14.1.1
34. Park M.J., Lee W.J., Lim H.K., et al. Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom Imaging 2009;34(4):441–7. doi: 10.1007/s00261-008-9424-4
35. Zou H., Zhao Y. 18FDG PET-CT for detecting gastric cancer recurrence after surgical resection: a meta-analysis. Surg Oncol 2013;22(3):162–6. doi: 10.1016/j.suronc.2013.05.001
36. De Potter T., Flamen P., Van Cutsem E., et al. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging. 2002;29(4):525–9. doi: 10.1007/s00259-001-0743-8
37. Liu N.B., Zhu L., Li M.H., et al. Diagnostic value of 18F-FDG PET/CT in comparison to bone scintigraphy, CT and 18F-FDG PET for the detection of bone metastasis. Asian Pac J Cancer Prev 2013;14(6):3647–52. doi: 10.7314/apjcp.2013.14.6.3647.
Review
For citations:
Amelina I.D., Galkova Z.V., Dolgushin B.I., Izrailov R.E., Karmazanovskii G.G., Kashin S.V., Kim V.A., Kulezneva Yu.V., Malikhova O.A., Medvedeva B.M., Nedoluzhko I.Yu., Parfenchikova E.V., Pirogov S.S., Semenov N.E., Solodinina E.N., Starkov Yu.G., Tkachenko O.B., Shevkunov L.N., Shishin K.V., Shchadrova V.V. Russian consensus on prevention, diagnosis and treatment of gastric cancer. Questions of instrumental diagnostics. Malignant tumours. 2025;15(2):66-72. (In Russ.) https://doi.org/10.18027/2224-5057-2024-047
Views:
51
Email this article 